Main Approaches to Enhance Radiosensitization in Cancer Cells by Nanoparticles: A Systematic Review.
Cancer
Nanoparticle
Radiation therapy
Radio-sensitization
Journal
Advanced pharmaceutical bulletin
ISSN: 2228-5881
Titre abrégé: Adv Pharm Bull
Pays: Iran
ID NLM: 101578021
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
19
02
2020
revised:
01
06
2020
accepted:
13
07
2020
entrez:
21
4
2021
pubmed:
22
4
2021
medline:
22
4
2021
Statut:
ppublish
Résumé
In recent years, high atomic number nanoparticles (NPs) have emerged as promising radio-enhancer agents for cancer radiation therapy due to their unique properties. Multi-disciplinary studies have demonstrated the potential of NPs-based radio-sensitizers to improve cancer therapy and tumor control at cellular and molecular levels. However, studies have shown that the dose enhancement effect of the NPs depends on the beam energy, NPs type, NPs size, NPs concentration, cell lines, and NPs delivery system. It has been believed that radiation dose enhancement of NPs is due to the three main mechanisms, but the results of some simulation studies failed to comply well with the experimental findings. Thus, this study aimed to quantitatively evaluate the physical, chemical, and biological factors of the NPs. An organized search of PubMed/Medline, Embase, ProQuest, Scopus, Cochrane and Google Scholar was performed. In total, 77 articles were thoroughly reviewed and analyzed. The studies investigated 44 different cell lines through 70
Identifiants
pubmed: 33880343
doi: 10.34172/apb.2021.025
pmc: PMC8046397
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
212-223Informations de copyright
© 2021 The Authors.
Références
Phys Med. 2016 Dec;32(12):1852-1861
pubmed: 27866898
Int J Radiat Biol. 1994 Jan;65(1):27-33
pubmed: 7905906
Acta Biochim Biophys Sin (Shanghai). 2012 Aug;44(8):678-84
pubmed: 22710262
J Drug Deliv. 2012;2012:751075
pubmed: 22007307
Free Radic Biol Med. 2001 May 1;30(9):1008-18
pubmed: 11316581
Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):633-5
pubmed: 19014777
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
CA Cancer J Clin. 2016 Jul;66(4):271-89
pubmed: 27253694
Radiother Oncol. 2014 Feb;110(2):342-7
pubmed: 24444528
Cancer Biol Med. 2014 Jun;11(2):86-91
pubmed: 25009750
Mutat Res. 2009 Mar-Jun;681(2-3):241-258
pubmed: 19041420
Bioimpacts. 2013;3(1):29-35
pubmed: 23678467
PLoS One. 2013 Apr 30;8(4):e62425
pubmed: 23638079
MAGMA. 2019 Aug;32(4):487-500
pubmed: 30730021
Int J Nanomedicine. 2012;7:2673-85
pubmed: 22701316
Biomaterials. 2016 Oct;105:127-135
pubmed: 27521615
Cancer Lett. 2014 Apr 28;346(1):53-62
pubmed: 24333735
Adv Drug Deliv Rev. 2017 Jan 15;109:84-101
pubmed: 26712711
J Clin Pharm Ther. 2007 Feb;32(1):41-7
pubmed: 17286788
Int J Radiat Biol. 2017 Mar;93(3):315-323
pubmed: 27690719
J Phys Chem C Nanomater Interfaces. 2012 Nov 1;116(43):23047-23052
pubmed: 23393610
Biomaterials. 2012 Feb;33(5):1477-88
pubmed: 22098780
Phys Med Biol. 2004 Sep 21;49(18):N309-15
pubmed: 15509078
Nanomedicine (Lond). 2010 Jan;5(1):51-64
pubmed: 20025464
Bioimpacts. 2014;4(1):15-20
pubmed: 24790894
Biomaterials. 2016 Sep;101:1-9
pubmed: 27254247
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
Toxicol In Vitro. 2019 Jun;57:18-27
pubmed: 30738203
Radiother Oncol. 2011 Sep;100(3):412-6
pubmed: 21924786
Int J Nanomedicine. 2016 Oct 12;11:5323-5333
pubmed: 27789945
Nanomedicine. 2014 Nov;10(8):1751-5
pubmed: 24941464
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):531-9
pubmed: 21095075
Toxicology. 2005 Sep 15;213(1-2):66-73
pubmed: 15970370
Science. 2006 Feb 3;311(5761):622-7
pubmed: 16456071
FEBS Lett. 2000 Jun 16;475(2):121-6
pubmed: 10858501
J Mater Chem B. 2018 Apr 21;6(15):2250-2257
pubmed: 32254565
Int J Nanomedicine. 2017 Feb 21;12:1431-1439
pubmed: 28260889
Radiat Res. 2014 Nov;182(5):475-88
pubmed: 25361396
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S922-S930
pubmed: 30307330
Toxicol Sci. 2005 Dec;88(2):412-9
pubmed: 16014736
Biomed Res Int. 2014;2014:498420
pubmed: 25165707
Int J Radiat Biol. 2014 May;90(5):351-6
pubmed: 24475739
Ann Ist Super Sanita. 2003;39(3):405-10
pubmed: 15098562
Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:833-841
pubmed: 30678974
Cancer Nanotechnol. 2016;7(1):8
pubmed: 27867425
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5372-6
pubmed: 25870296
Contemp Oncol (Pozn). 2019;23(1):7-15
pubmed: 31061631
Radiother Oncol. 2017 Sep;124(3):344-356
pubmed: 28784439
Adv Drug Deliv Rev. 2008 Dec 14;60(15):1600-14
pubmed: 18840487
Nanotechnology. 2016 Sep 23;27(38):385104
pubmed: 27533280
Phys Med Biol. 2017 Sep 15;62(19):7729-7740
pubmed: 28832337
Biointerphases. 2007 Dec;2(4):MR17-71
pubmed: 20419892
Nanomedicine. 2013 May;9(4):558-69
pubmed: 23178284
Biomaterials. 2017 Jan;112:257-263
pubmed: 27768978
J Biomed Phys Eng. 2019 Feb 01;9(1):89-96
pubmed: 30881938
Med Phys. 2017 Nov;44(11):5949-5960
pubmed: 28886212
Phys Med Biol. 2010 Feb 21;55(4):931-45
pubmed: 20090183
Cancer Nanotechnol. 2014;5(1):6
pubmed: 25328549
Nanotechnology. 2018 Dec 14;29(50):504001
pubmed: 30229748
Breast Cancer. 2015 Jul;22(4):413-20
pubmed: 24114595
Nanomedicine. 2013 Oct;9(7):1089-97
pubmed: 23643529
Phys Med Biol. 2014 May 7;59(9):2249-63
pubmed: 24733041
Nanoscale. 2016 Feb 7;8(5):2678-85
pubmed: 26757746
Nanotoxicology. 2011 Mar;5(1):43-54
pubmed: 21417687
Nanomedicine. 2009 Jun;5(2):136-42
pubmed: 19480049
Int J Nanomedicine. 2018 Jun 19;13:3541-3552
pubmed: 29950834
Cancer. 2005 Sep 15;104(6):1129-37
pubmed: 16080176
J Drug Target. 2019 Aug;27(7):762-766
pubmed: 30252540
Phys Med Biol. 2015 Jun 7;60(11):4449-64
pubmed: 25988839
Nanotechnology. 2010 Jul 23;21(29):295101
pubmed: 20601762
Future Oncol. 2012 Sep;8(9):1167-81
pubmed: 23030491
Int J Pharm. 2017 Mar 30;520(1-2):126-138
pubmed: 28167261
Int J Nanomedicine. 2018 Mar 15;13(T-NANO 2014 Abstracts):113-115
pubmed: 29593408
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):132-143
pubmed: 30663430
Science. 2000 Mar 3;287(5458):1658-60
pubmed: 10698742
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
pubmed: 18287387
Biochim Biophys Acta. 2015 Aug;1856(1):130-43
pubmed: 26142869
Int J Med Sci. 2017 May 15;14(6):602-614
pubmed: 28638277
Nanotechnology. 2011 Jul 15;22(28):285101
pubmed: 21654036
Biochem Biophys Res Commun. 1996 Mar 27;220(3):643-7
pubmed: 8607818
Int J Radiat Biol. 2000 Oct;76(10):1357-64
pubmed: 11057744
Mutat Res. 2010 Apr-Jun;704(1-3):123-31
pubmed: 20074660
Small. 2010 Oct 18;6(20):2246-9
pubmed: 20818619
Free Radic Biol Med. 1990;8(6):583-99
pubmed: 2193855
Cancer Nanotechnol. 2014;5(1):5
pubmed: 25243023
Nanotechnology. 2008 Jul 23;19(29):295104
pubmed: 21730596
Adv Healthc Mater. 2014 Jan;3(1):133-41
pubmed: 23873780
Nanotechnology. 2009 Sep 16;20(37):375101
pubmed: 19706948
Int J Mol Sci. 2019 Jan 30;20(3):
pubmed: 30704035
Environ Mol Mutagen. 2008 Jun;49(5):399-405
pubmed: 18418868
Radiat Res. 2012 Dec;178(6):604-8
pubmed: 23148509
Am J Physiol Lung Cell Mol Physiol. 2004 Feb;286(2):L344-53
pubmed: 14555462
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Toxicol In Vitro. 2011 Feb;25(1):231-41
pubmed: 21092754
J Biomed Nanotechnol. 2016 Mar;12(3):464-71
pubmed: 27280244
Biomaterials. 2012 Sep;33(27):6408-19
pubmed: 22681980
Int J Nanomedicine. 2015 Jun 11;10:3937-53
pubmed: 26185437
Nanoscale Res Lett. 2017 Dec;12(1):225
pubmed: 28351128
Mol Med Rep. 2017 Dec;16(6):9005-9010
pubmed: 28990103
Radiat Res. 2017 Feb;187(2):147-160
pubmed: 28085639
Artif Cells Nanomed Biotechnol. 2018;46(sup2):836-846
pubmed: 29741418
Phys Rev Lett. 2004 Aug 6;93(6):068101
pubmed: 15323664
Radiat Res. 2010 Jun;173(6):719-28
pubmed: 20518651
Colloids Surf B Biointerfaces. 2009 Aug 1;72(1):128-34
pubmed: 19414242
Pathobiology. 2007;74(6):353-8
pubmed: 18087200
Free Radic Res. 2016 Dec;50(12):1319-1328
pubmed: 27778515
ACS Nano. 2011 Jul 26;5(7):5478-89
pubmed: 21692495
Int J Mol Epidemiol Genet. 2011;2(4):367-90
pubmed: 22199999
Nat Mater. 2009 Jul;8(7):543-57
pubmed: 19525947
Breast Cancer Res Treat. 2013 Jan;137(1):81-91
pubmed: 23160926
Clin Invest Med. 2008;31(3):E160-7
pubmed: 18544279
Small. 2008 Sep;4(9):1537-43
pubmed: 18712753